Tissue Engineering And Nanotheranostics

(Steven Felgate) #1
b2815 Tissue Engineering and Nanotheranostics “9.61x6.69”

252 Tissue Engineering and Nanotheranostics


of different agents or tools together to the target tissues is still chal­


lenging. The rapid development of nanotechnology provides a new


impetus for cancer therapy due to its unique physical properties. For


example, mesoporous silica­encapsulated gold nanorods (GNRs@


mSiO 2 ) as a NIR­light­absorbing agent and a drug delivery system for


in vivo chemo­photothermal destruction of tumor were developed.^329


In order to target the tumor and increase the therapeutic efficacy,


RGD peptides were conjugated on the terminal groups of PEG on


GNRs@mSiO 2. DOX was also successfully loaded into pGNRs@


mSiO 2 ­RGD nanomaterials. The results proved that the synergistic


effect of DOX–pGNRs@mSiO 2 –RGD for the efficacious treatment of


tumor were better than that of the chemotherapy or photothermal


therapy alone. The side effects of antitumor drugs and low treatment


efficacy are two major challenges of current chemotherapy. To address


these issues, a new kind of smart nanocarriers based on upconversion


nanoparticle (UCN)­loaded folate­conjugated polymeric lipid vesicles


(UFPLVs) that combine pH­responsive chemotherapy and NIR­


light­triggered photodynamic therapy were constructed. Merocyanine


540 (MC540), as a photosensitizer, was loaded in the UFPLVs; DOX


was conjugated to the surfaces of UFPLVs by pH­sensitive hydrazone


bonds. In vitro and in vivo combination treatments evidenced the


high antitumor effects of MC540@DOX­UFPLVs under NIR­light­


irradiation.^330 Checkpoint inhibitors are among the most promising


immunotherapies for patients with advanced colon cancer, but their


durable response rate remains low. He et al. reported the use of


immunogenic nanoparticles to augment the antitumor efficacy of


PD­L1 antibody­mediated cancer immunotherapy. Nanoscale coordi­


nation polymer core–shell nanoparticles carry oxaliplatin in the core


and the photosensitizer pyropheophorbide­lipid conjugate in the shell


for effective chemotherapy and PDT.^331


Theranostics, the integration of therapeutics and diagnostics into a


system, is a recently proposed concept.42,47,332–334 It can provide real­


time monitoring of the treatment process, and improve therapeutic


efficiency with better planning and prognosis. The treatment methods


include chemo/gene/PTT/PDT, and diagnostic technologies with


fluorescence/bioluminescence, MRI, PET, SPECT, photoacoustic,

Free download pdf